Soleno Therapeutics (SLNO) EPS (Basic): 2013-2017
Historic EPS (Basic) for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to -$0.40.
- Soleno Therapeutics' EPS (Basic) rose 79.90% to -$0.40 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.78, marking a year-over-year increase of 99.20%. This contributed to the annual value of -$4.38 for FY2024, which is 85.59% down from last year.
- As of Q4 2017, Soleno Therapeutics' EPS (Basic) stood at -$0.40, which was down 2.56% from -$0.39 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' EPS (Basic) registered a high of $0.82 during Q4 2014, and its lowest value of -$220 during Q1 2016.
- In the last 3 years, Soleno Therapeutics' EPS (Basic) had a median value of -$0.41 in 2017 and averaged -$18.89.
- In the last 5 years, Soleno Therapeutics' EPS (Basic) skyrocketed by 145.05% in 2014 and then slumped by 13,073.65% in 2016.
- Soleno Therapeutics' EPS (Basic) (Quarterly) stood at -$1.82 in 2013, then surged by 145.05% to $0.82 in 2014, then tumbled by 110.98% to -$0.09 in 2015, then crashed by 2,111.11% to -$1.99 in 2016, then spiked by 79.90% to -$0.40 in 2017.
- Its last three reported values are -$0.40 in Q4 2017, -$0.39 for Q3 2017, and -$0.42 during Q2 2017.